Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zimmer Biomet Holdings Inc. shares valued at $4,287,248 were sold by Phipps Chad F on Mar 17. At $121.97 per share, Phipps Chad F sold 35,149 shares. The insider’s holdings dropped to 41,539 shares worth approximately $4.37 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Also, Yi Sang sold 2,800 shares, netting a total of over 347,599 in proceeds. Following the sale of shares at $124.14 each, the insider now holds 5,837 shares.
As published in a research note from Needham on May 27, 2022, Zimmer Biomet Holdings Inc. [ZBH] has been rated down from a Buy to a Hold. Analysts at Truist downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid April. As of April 01, 2022, Citigroup has decreased its “Buy” rating to a “Neutral” for ZBH.
Analyzing ZBH’s Price Performance
On Wednesday, Zimmer Biomet Holdings Inc. [NYSE: ZBH] rose 3.01% to $105.31. The stock’s lowest price that day was $101.22, but it reached a high of $107.20 in the same session. During the last five days, there has been a surge of approximately 0.04%. Over the course of the year, Zimmer Biomet Holdings Inc. shares have dropped approximately -14.55%. Shares of the company reached a 52-week high of $135.05 on 04/21/22 and a 52-week low of $101.22 on 06/22/22. A 50-day SMA is recorded $118.88, while a 200-day SMA reached $127.97. Nevertheless, trading volume fell to 1.75 million shares from 1.24 million shares the previous day.
Support And Resistance Levels for Zimmer Biomet Holdings Inc. (ZBH)
According to the 24-hour chart, there is a support level at 101.95, which, if violated, would cause prices to drop to 98.60. In the upper region, resistance lies at 107.93. The next price resistance is at 110.56. RSI (Relative Strength Index) is 34.60 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -8.24, which suggests the price will decrease in the coming days. Percent R is at 80.51%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Zimmer Biomet Holdings Inc. subject to short interest?
Stocks of Zimmer Biomet Holdings Inc. saw a sharp rise in short interest on Apr 28, 2022 jumping by 80000.0 shares to 3.51 million. Data from Yahoo Finance shows that the short interest on Mar 30, 2022 was 3.43 million shares. A jump of 2.28% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.53 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.53.
Which companies own the most shares of Zimmer Biomet Holdings Inc. (ZBH)?
According to The Vanguard Group, Inc. filings, the company currently owns 22,277,407 shares, which is about 10.63% of the total ZBH shares outstanding. The investor’s shares have appreciated by 3,712,463 from its previous 13-F filing of 18564944.0 shares. With the completion of the buy, BlackRock Fund Advisors’s stake is now worth $1,322,339,572. SSgA Funds Management, Inc. reduced a -1.17% interest valued at $1.07 billion while JPMorgan Investment Management, I purchased a 951,171 stake. A total of -317,227 shares of Zimmer Biomet Holdings Inc. were bought by T. Rowe Price Associates, Inc. during the quarter, and 272,469 were bought by American Century Investment Manag. In its current portfolio, Capital Research & Management Co holds 5,638,192 shares valued at $677.77 million.
In terms of Zimmer Biomet Holdings Inc. share price expectations, FactSet research, analysts set an average price target of $129.58 in the next 12 months, up nearly 27.16% from the previous closing price of $102.23. Analysts anticipate Zimmer Biomet Holdings Inc. stock to reach $145.00 by 2022, with the lowest price target being $114.00. In spite of this, 25 analysts ranked Zimmer Biomet Holdings Inc. stock as a Hold at the end of 2022. On March 02, 2022, Loop Capital assigned a price target of “a Hold” to the stock and downgraded coverage with a $130.